The Department of Health and Human Services Food and Drug Administration awarded a $249,999.00 definitive contract to Hartford Hospital, a non-profit hospital organization, to conduct research and development in support of regulatory science and innovation. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which solicits proposals across eight areas of regulatory science to modernize FDA functions. The contract does not have...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, with a potential value of $249,991.00, is for research on the pharmacodynamics of three antibiotics - minocycline, levofloxacin, and trimethoprim/sulfamethoxazole - against the bacterium Stenotrophomonas maltophilia. The goal of the research is to provide data to support potential...
This is a $539,764.16 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract is for emergency medical simulation training services, with a performance period through May 14, 2023. Hartford Hospital has previously conducted research for the Food and Drug Administration and provided clinical services in support of multi-site studies funded by the National...
This federal contract award, valued at $450,714.35, was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Hartford Hospital, a non-profit healthcare institution and subsidiary of Hartford Healthcare Corporation. The contract is for emergency medical simulation training services and does not have a set-aside designation. This award demonstrates Hartford Hospital's expertise in providing advanced medical research and simulation services to federal...
The University of Connecticut (UConn) has been awarded a $1,103,886 firm-fixed-price definitive federal contract by the Food and Drug Administration (FDA) for research and development related to the impact of active pharmaceutical ingredients on in situ forming implants and understanding in vitro and in vivo performance differences. This contract, which has a completion date of September 29, 2026, was issued under the FDA's Broad Agency Announcement for research and development to support...
Yale University was awarded a definitive cost-no-fee contract valued at $3.3 million by the Department of Health and Human Services Food and Drug Administration to support the agency's Broad Agency Announcement for Advanced Research and Development of Regulatory Science. The prime contractor will leverage community engagement and electronic health record strategies to promote diverse participation in COVID-19 clinical trials, addressing Research Area 9 under the BAA which seeks proposals to...
The federal contract award is for a definitive contract with the Food and Drug Administration (FDA) for human food inspection services in Hartford, Connecticut. The $372,314.29 firm fixed price contract was awarded on August 29, 2023 to the Connecticut Department of Consumer Protection, a U.S. state government entity, to provide these inspection services from August 2023 through March 2027. This contract was awarded without any set-asides. In addition to the contract award, the Department of...
The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation. Under the contract, Brigham & Women's Hospital is working closely with the FDA's...
The University of Connecticut has been awarded a definitive contract by the Department of Health and Human Services Food and Drug Administration to continue processing liposomal nanoparticles as reference materials for drug product development. With a potential value of $349,364, this time and materials contract does not have a set-aside designation and is to be completed by May 31, 2023. As the prime contractor, the University will utilize its expertise in nanotechnology and materials...
The Department of Health and Human Services Food and Drug Administration awarded a $2,963,836.42 firm fixed price delivery order contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract supports developing capability to use Medicaid data for FDA post-market drug safety surveillance during pregnancy. This contract is a task order under the FDA's Scientific Pharmacoepidemiologic Research Program, a larger...